CR Bard Inc (BCR)

BCR (NYSE:Health Services)
$166.50
pos +0.00
+0.00%
Today's Range: 166.24 - 169.09 | BCR Avg Daily Volume: 511,100
Last Update: 11/21/14 - 4:01 PM EST
Volume: 0
YTD Performance: 24.31%
Open: $0.00
Previous Close: $167.11
52 Week Range: $125.00 - $169.09
Oustanding Shares: 74,898,741
Market Cap: 12,516,328,609
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 9 9 9 10
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 2.95 2.95 2.95 2.95
Latest Dividend: 0.22
Latest Dividend Yield: 0.53%
Dividend Ex-Date: 10/16/14
Price Earnings Ratio: 16.45
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
16.45 16.20 25.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.97% 19.74% 97.67%
GROWTH 12 Mo 3 Yr CAGR
Revenue 3.10 0.12 0.04
Net Income 30.10 0.35 0.11
EPS 38.80 0.58 0.16
Earnings for BCR:
EBITDA 0.79B
Revenue 3.05B
Average Earnings Estimates
Qtr (12/14) Qtr (03/15) FY (12/14) FY (12/15)
Average Estimate $2.24 $2.14 $8.36 $9.25
Number of Analysts 9 5 12 12
High Estimate $2.25 $2.19 $8.38 $9.53
Low Estimate $2.21 $2.10 $8.33 $9.00
Prior Year $1.42 $1.91 $5.78 $8.36
Growth Rate (Year over Year) 57.67% 12.15% 44.65% 10.65%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Nov 17, 2014 | 4:33 AM EST

There's a powerful collection of "what's working."

By

John Reese

 | Oct 11, 2014 | 10:30 AM EDT

These stocks are all worth your consideration.

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

bearishCR Bard downgraded at BofA/Merrill

Apr 7, 2014 | 8:19 AM EDT

BCR was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $150 price target. 

bearishCR Bard downgraded at JP Morgan

Jan 6, 2014 | 8:33 AM EST

BCR was downgraded from Overweight to Neutral, JP Morgan said. Valuation call, as the stock gained 37% in 2013. 

bullishCR Bard upgraded at Piper

Oct 23, 2013 | 8:14 AM EDT

BCR was upgraded from Neutral to Overweight, Piper Jaffray said. $140 price target. Organic growth profile is improving. 

bullishCR Bard upgraded at Goldman

Oct 23, 2013 | 7:51 AM EDT

BCR was upgraded from Sell to Neutral, Goldman Sachs said. Negative catalysts have been realized. $132 price target.

By

Timothy Collins

 | Sep 9, 2013 | 1:10 PM EDT

These 15 stocks have similar price patterns and technical setups.

By

Sham Gad

 | Sep 8, 2013 | 8:00 AM EDT

For most investors, this simple strategy is the way to go.

By

Robert Moreno

 | Apr 4, 2013 | 1:41 PM EDT

Occasionally there is unusual technical synchronization on multiple timeframes.

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.